NIH-funded research U01 cooperative agreement

Telehealth glaucoma screening for high-risk patients

Official title: DP24-081 Novel telehealth technologies to detect and manage glaucoma and vision-threatening eye diseases in high-risk populations

Funded at University of California, San Francisco · NIH-11358977 · Data updated 2026-11-12

A new telemedicine program will check for glaucoma in Black and Latino people at community clinics to catch and manage eye disease early.

More Glaucoma research and trials

Quick facts

Grant typeU01 cooperative agreement
Study typeNIH-funded research
Funding institutionUniversity of California, San Francisco
NIH-funded
Lab location1 site (San Francisco, United States)
Project startSeptember 30, 2024
Project endSeptember 29, 2027
Funding year2026
Award (this year)$700,000
NIH project number5U01DP006820-03
Project IDNIH-11358977 on NIH RePORTER

Who could benefit from this research

Could help

Adults at high risk for glaucoma who receive care at FQHCs in Northern California and are able to participate in telemedicine screening.

Less likely to help

Individuals who do not have access to or prefer in-person eye exams may not experience a direct benefit.

What this research studies

This project tests a telehealth screening approach in Federally Qualified Health Centers to find glaucoma earlier in high-risk populations. It will compare telemedicine screening to mailed educational materials and a delayed screening group, looking at how well each detects glaucoma and other eye problems. The study aims to see if telehealth not only finds glaucoma but also helps identify cataracts or refractive errors and whether it is cost-effective. The trial is conducted in Northern California at clinics serving underserved communities and is led by UC San Francisco.

Why it matters

Potential benefit: If successful, this approach could lead to earlier detection and treatment of glaucoma in high-risk groups, potentially preventing vision loss.

How similar studies have gone: Previous studies suggest telemedicine can aid in screening, but this trial tests feasibility and cost-effectiveness in high-risk populations.

Where this research is happening

  • University of California, San Francisco
    San Francisco, United States
    Active

Researchers

  • Principal investigator: Keenan, Jeremy David — University of California, San Francisco
  • Study coordinator: Keenan, Jeremy David

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.